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article under the CC BY-NC-ND licenseAbstract Extensive prostatic calculi in a young man should always elicit the suspicion of al-
kaptonuria. Although prostatic calculi are seen in chronic prostatitis, chronic pelvic pain syn-
drome and benign prostate hyperplasia, none of these have prostatic calculi or calcification as
extensive as in alkaptonuria. A 36 years young man who had severed obstructive lower urinary
tract symptoms with extensive prostatic calculi was found to be alkaptonuric on further eval-
uation.
ª 2015 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Alkaptonuria is a rare hereditary disease due to inborn error
of metabolism in homogentisate 1,2-dioxygenase (HGD)
enzyme.This enzyme is involved in the metabolism of the
tyrosine. Deficiency in HGD leads to deposition of homo-
gentisic acid and its oxidized product benzoquinone acetic
acid (BQA) in the various tissues called as ochronosis.
Ochronosis leads to renal and prostatic calculi, sialoli-
thiasis, cholelithiasis, pigmentation of the skin,om (G. Sali).
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(http://creativecommons.org/limusculoskeletal abnormalities, and cardiac valve calcifi-
cation. We present a case of 36 years man who presented
with bothersome lower urinary tract symptoms (LUTS) and
was found to be alkaptonuric on further evaluation.
2. Case
A 36 years man presented with severe obstructive LUTS. On
digital rectal examination prostate was hard and nodular.
Flow was a Qmax of 2 mL/s for a voided volume of 130 mL
and post void residual urine volume of 380 mL. Prostate
specific antigen (PSA) was 0.393 ng/mL, while X-ray of
pelvis showed punctate calcification in the region of pubic
symphysis (Fig. 1), computerized tomography scan of pelvis
showed extensive and well calcified areas into the prostaticn and hosting by Elsevier (Singapore) Pte Ltd. This is an open access
censes/by-nc-nd/4.0/).
Figure 1 Punctate calcification in the region of pubic
symphysis by X-ray of pelvis.
Figure 2 Extensive prostatic calcification by computerized
tomography.
Figure 4 Cystoscopic view of prostatic urethra cont
Figure 3 Osler’s sign.
180 G. Sali et al.parenchyma (Fig. 2). On further evaluation, he gave history
of passage of dark colored urine and chronic low back ache.
He was short statured with kyphotic spine. Osler’s sign
(bluish discolouration of sclera) was present (Fig. 3).
Biochemical analysis of urine showed the presence of
homogentisic acid. These findings confirmed the diagnosis
of alkaptonuria. He underwent transurethtral clearance of
prostatic calculi which revealed multiple blackish calculi in
prostatic urethra and in prostatic fossa (Fig. 4) and clear-
ance of calculi. On biochemical analysis, calculi were
composed of calcium oxalate and uric acid.
3. Discussion
Hard prostate is a common manifestation of carcinoma of
prostate, but in presence of extensive prostatic calculi
and normal PSA level in a young man carcinoma of a
prostate should not be serious diagnostic consideration.
Prostatic calculi are common with incidence varying from
7.35% [1] to 71% [2] but usually they are asymptomatic and
are discovered incidentally. Conditions associated with
prostatic calculi are chronic prostatitis, chronic pelvic
pain syndrome and benign prostate hyperplasia but none
of these have prostatic calculi or calcification as extensive
as alkaptonuria. Patients with alkaptonuria have tendency
to form stones, because homogentisic acid may act as a
chemical irritant, causing inflammation or it is also
possible that HGA physically binds to connective tissue
and alters the structure and interactions of the macro-
molecules [3]. In alkaptonuria calculi are also formed in
kidney, gall bladder, and salivary glands. Although intra-
prostatic reflux of urine containing high levels homoge-
ntisic acid may be responsible for extensive calcification
in prostate, the exact mechanism is not known. Prostatic
calculi is one of the manifestations of alkaptonuria and is
reported in two reports [4,5] but they were incidental
findings and asymptomatic. There is only one report in
which patient with alkaptonuria had a hard prostate
clinically mimicking a carcinoma, secondary to the diffuse
deposition of calculi [6]. In a report by Decramer et al.
[7], an alkaptonuric patient had prostatic calculi leading
to chronic prostatitis. A thorough search of literature
revealed only one case report [8] where patient with
alkaptonuria had bothersome LUTS and underwent tran-
surethtral clearance of prostatic calculi but in this report
patient was 50 years old.
No treatment modality has been unequivocally demon-
strated to reduce the complications of alkaptonuria. Main
treatment attempts have focused on preventing ochronosisaning calculi and postprocedure extracted calculi.
Extensive prostatic calculi in alkaptonuria 181through the reduction of accumulating homogentisic acid.
Such commonly recommended treatments include large
doses of ascorbic acid (vitamin C) or dietary restriction of
amino acids phenylalanine and tyrosine. However, neither
vitamin C treatment nor protein restriction (which can be
difficult to adhere to) has not shown to be effective in
clinical studies [9]. A potential disease modifying drug,
Nitisinone, inhibits 4-hydroxy-phenyl-pyruvate-dioxygenase
and decreases formation of HGA and could prevent or slow
the progression of disease in alkaptonuria [9], but its effi-
cacy is yet to be proved. So treatment of alkaptonuria is
symptomatic and palliative in early stages with surveillance
for cardiac, renal, and prostate complications. This case of
alkaptonuria is unique for its presentation with extensive
prostatic calcification. Strong clinical suspicion is required
to diagnose alkaptonuria. Although, alkaptonuria (also
known as black urine disease, black bone disease) is rare
disease with incidence of 1 in 250,000 to 1,000,000 of
general population [10] thorough history with physical ex-
amination is necessary so that this condition would not
remain unnoticed. The paucity of published cases could be
due to the fact that many cases would have gone unnoticed
or not reported.
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